Literature DB >> 16694720

THE OCCURRENCE OF METHEMOGLOBINEMIA DURING SULFANILAMIDE THERAPY.

C L Fox1, J E Cline.   

Abstract

Entities:  

Year:  1940        PMID: 16694720      PMCID: PMC434948          DOI: 10.1172/JCI101106

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


× No keyword cloud information.
  3 in total

1.  CYANOSIS WITHOUT SULF- OR METHEMOGLOBINEMIA IN PATIENTS RECEIVING SULFANILAMIDE TREATMENT.

Authors:  L C Chesley
Journal:  J Clin Invest       Date:  1938-07       Impact factor: 14.808

2.  THE CONTROL OF METHEMOGLOBINEMIA WITH METHYLENE BLUE.

Authors:  W B Wendel
Journal:  J Clin Invest       Date:  1939-03       Impact factor: 14.808

3.  THE FORMATION OF METHEMOGLOBIN AND SULFHEMOGLOBIN DURING SULFANILAMIDE THERAPY.

Authors:  J S Harris; H O Michel
Journal:  J Clin Invest       Date:  1939-09       Impact factor: 14.808

  3 in total
  2 in total

1.  ACUTE HEMOLYTIC ANEMIA FROM THE SULFONAMIDES.

Authors:  C L Fox; R Ottenberg
Journal:  J Clin Invest       Date:  1941-09       Impact factor: 14.808

2.  SPECTROPHOTOMETRY OF FAIRLEY'S NEW BLOOD PIGMENT, METHEMALBUMIN.

Authors:  C L Fox
Journal:  J Clin Invest       Date:  1941-09       Impact factor: 14.808

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.